Skip to content
10-Q

Quarterly Report

Sienna Biopharmaceuticals, Inc.

0001193125-19-216859

← back to feed
Filed
Aug 8, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 6, 2019 30.91M sh
Capex Q2 2019 · Jun 30, 2019 $4K
Capex Q2 2019 · Jun 30, 2018 $17K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$21.19M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$30.21M
Long Term Debt Q2 2019 · Jun 30, 2019 $29.47M
Long Term Debt Q2 2019 · Dec 31, 2018 $30.13M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $49.21M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $48.53M
Stockholders Equity Q2 2019 · Jun 30, 2019 $26.98M
Stockholders Equity Q2 2019 · Mar 31, 2019 $33.29M
Stockholders Equity Q2 2019 · Dec 31, 2018 $26.58M
Stockholders Equity Q2 2019 · Jun 30, 2018 $55.53M
Stockholders Equity Q2 2019 · Mar 31, 2018 $76.42M
Stockholders Equity Q2 2019 · Dec 31, 2017 $91.2M
Current Liabilities Q2 2019 · Jun 30, 2019 $20.81M
Current Liabilities Q2 2019 · Dec 31, 2018 $24.35M
Total Liabilities Q2 2019 · Jun 30, 2019 $80.64M
Total Liabilities Q2 2019 · Dec 31, 2018 $80.73M
Current Assets Q2 2019 · Jun 30, 2019 $50.62M
Current Assets Q2 2019 · Dec 31, 2018 $50.41M
Total Assets Q2 2019 · Jun 30, 2019 $107.63M
Total Assets Q2 2019 · Dec 31, 2018 $107.31M
Sga Expense Q2 2019 · Jun 30, 2019 $2.64M
Sga Expense Q2 2019 · Jun 30, 2019 $11.39M
Sga Expense Q2 2019 · Jun 30, 2018 $5.98M
Sga Expense Q2 2019 · Jun 30, 2018 $11.47M
Rd Expense Q2 2019 · Jun 30, 2019 $5.08M
Rd Expense Q2 2019 · Jun 30, 2019 $12.18M
Rd Expense Q2 2019 · Jun 30, 2018 $15.69M
Rd Expense Q2 2019 · Jun 30, 2018 $28.67M
Net Income Q2 2019 · Jun 30, 2019 −$8.26M
Net Income Q2 2019 · Jun 30, 2019 −$24.65M
Net Income Q2 2019 · Mar 31, 2019 −$16.38M
Net Income Q2 2019 · Jun 30, 2018 −$20.24M
Net Income Q2 2019 · Jun 30, 2018 −$37.34M
Net Income Q2 2019 · Mar 31, 2018 −$17.1M
Operating Income Q2 2019 · Jun 30, 2019 −$7.73M
Operating Income Q2 2019 · Jun 30, 2019 −$23.57M
Operating Income Q2 2019 · Jun 30, 2018 −$21.67M
Operating Income Q2 2019 · Jun 30, 2018 −$40.15M